GENEVA, Dec. 30 -- OHARA PHARMACEUTICAL CO., LTD. (121-15, Toriino, Koka-cho, Koka-shi, Shiga5203403), 大原薬品工業株式会社 (滋賀県甲賀市甲賀町鳥居野１２１番地１５) filed a patent application (PCT/JP2025/022214) for "CRYSTALLINE FORM OF ORAL DNMT INHIBITOR" on Jun 19, 2025. With publication no. WO/2025/263591, the details related to the patent application was published on Dec 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Invent...